197 related articles for article (PubMed ID: 35655266)
1. Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies.
Wang L; Yu Y; Zhou C; Wan R; Li Y
Syst Rev; 2022 Jun; 11(1):109. PubMed ID: 35655266
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram's Anticancer Activity: Evidence and Mechanisms.
Jiao Y; Hannafon BN; Ding WQ
Anticancer Agents Med Chem; 2016; 16(11):1378-1384. PubMed ID: 27141876
[TBL] [Abstract][Full Text] [Related]
4. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
5. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
[TBL] [Abstract][Full Text] [Related]
6. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
[TBL] [Abstract][Full Text] [Related]
7. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
[TBL] [Abstract][Full Text] [Related]
8. The combination of disulfiram and copper for cancer treatment.
Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram: A novel repurposed drug for cancer therapy.
Zeng M; Wu B; Wei W; Jiang Z; Li P; Quan Y; Hu X
Chin Med J (Engl); 2024 Jun; 137(12):1389-1398. PubMed ID: 38275022
[TBL] [Abstract][Full Text] [Related]
10. Anti-Cancer Effects of Disulfiram in Cervical Cancer Cell Lines Are Mediated by Both Autophagy and Apoptosis.
Zhang W; Zhai Q; Li M; Huang S; Sun Z; Yan Z; Li J; Li L; Li Y
Bull Exp Biol Med; 2022 Mar; 172(5):642-648. PubMed ID: 35353287
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case.
Karamanakos PN; Trafalis DT; Papachristou DJ; Panteli ES; Papavasilopoulou M; Karatzas A; Kardamakis D; Nasioulas G; Marselos M
J BUON; 2017; 22(5):1227-1232. PubMed ID: 29135106
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C
Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
[TBL] [Abstract][Full Text] [Related]
14. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract][Full Text] [Related]
16. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram: a novel repurposed drug for cancer therapy.
Lu C; Li X; Ren Y; Zhang X
Cancer Chemother Pharmacol; 2021 Feb; 87(2):159-172. PubMed ID: 33426580
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms.
Sun F; Wang H; Nie J; Hong B
Anticancer Agents Med Chem; 2022; 22(17):2920-2926. PubMed ID: 35430981
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer.
Jiapaer Z; Zhang L; Ma W; Liu H; Li C; Huang W; Shao S
Biochem Biophys Res Commun; 2022 Dec; 635():291-298. PubMed ID: 36327916
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo.
Li Z; Xie X; Tan G; Xie F; Liu N; Li W; Sun X
Biol Pharm Bull; 2021; 44(9):1323-1331. PubMed ID: 34471060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]